Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management
-
Published:2019-09
Issue:
Volume:119
Page:97-106
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Gogas Helen J.,
Flaherty Keith T.,
Dummer Reinhard,
Ascierto Paolo A.,
Arance Ana,
Mandala Mario,
Liszkay Gabriella,
Garbe Claus,
Schadendorf DirkORCID,
Krajsova Ivana,
Gutzmer Ralf,
Sileni Vanna Chiarion,
Dutriaux Caroline,
de Groot Jan Willem B.,
Yamazaki Naoya,
Loquai Carmen,
Gollerkeri Ashwin,
Pickard Michael D.,
Robert Caroline
Funder
Array BioPharma, Inc.
Roche
Bristol-Myers Squibb
Merck Sharp & Dohme
Novartis
Amgen
Pierre Fabre
BMS
Genentech
Array
MSD
Merck
Amicus
Boehringer-Ingelheim
Boehringer Ingelheim
LEO Pharma
Incyte
Regeneron
4SC
AstraZeneca
EMD
Pfizer
Philogen
Array BioPharma
Johnson & Johnson
MerckSerono
Almirall-Hermal
Merck-Serono
Pierre-Fabre
SUN
Roche Pharma
Takeda
Servier
Ono Pharmaceutical
Subject
Cancer Research,Oncology
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献